Condition

Small Cell Lung Carcinoma (SCLC)

ClinicalTrials.gov condition label

Clinical trials6
Recruiting2
Common interventions11
Lead sponsors shown3

Clinical trials

6 shown
Safety, Pharmacokinetics and Preliminary Efficacy of CS231295 in Advanced Solid TumorsNCT06902350 · 2025-05-21
RECRUITING
A Study to Test How BI 764532 is Taken up by Tumours in People With Small-cell Lung Cancer or Neuroendocrine CancerNCT05963867 · 2024-08-06
RECRUITING
Evaluation of the Value of [68Ga]Ga-PENTIXAFOR PET-CT in Patients With Metastatic Small Cell Lung Cancer (SCLC)NCT07007325 · 2026-09-30
NOT_YET_RECRUITING
DAREONᵀᴹ-8: A Study to Test How Well Different Doses of BI 764532 in Addition to Standard of Care Are Tolerated by People With Advanced Small Cell Lung CancerNCT06077500 · 2024-02-14
ACTIVE_NOT_RECRUITING
DAREON™-9: A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With Small Cell Lung Cancer When Taken Together With a Single Agent ChemotherapyNCT05990738 · 2024-02-14
ACTIVE_NOT_RECRUITING
A Study to Test How Well Different Doses of Obrixtamig (BI 764532) in Combination With Ezabenlimab Are Tolerated by People With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3NCT05879978 · 2023-06-27
ACTIVE_NOT_RECRUITING

Trial status mix

ACTIVE_NOT_RECRUITING3
RECRUITING2
NOT_YET_RECRUITING1

Phase mix

PHASE15
EARLY_PHASE11

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.